Cargando...
Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in which the immune system plays a centralized role. Addit...
Gardado en:
| Publicado en: | Cureus |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cureus
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6126779/ https://ncbi.nlm.nih.gov/pubmed/30197847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2924 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|